pI: 4.5871 |
Length (AA): 672 |
MW (Da): 75272 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
230 | 412 | 5h78 (A) | 7 | 189 | 11.00 | 0 | 0.01 | 0.456521 | -0.97 |
502 | 669 | 1c1g (A) | 2 | 167 | 28.00 | 0.15 | 0.03 | 0.2204 | 1.12 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127902)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G66540 | hypothetical protein |
Babesia bovis | BBOV_IV001330 | U3 small nucleolar ribonucleoprotein protein, putative |
Brugia malayi | Bm1_21335 | Mpp10 protein |
Candida albicans | CaO19.9471 | similar to U3 snoRNP binding protein, part of the pre-18S rRNA processome |
Candida albicans | CaO19.1915 | U3 small nucleolar ribonucleoprotein (snoRNP) |
Caenorhabditis elegans | CELE_Y75B8A.7 | Protein Y75B8A.7 |
Cryptosporidium hominis | Chro.70400 | At5g66540/K1F13_21 |
Cryptosporidium parvum | cgd7_3590 | Mpp10 family of U3 processosome protein |
Dictyostelium discoideum | DDB_G0279245 | U3 small nucleolar ribonucleoprotein |
Drosophila melanogaster | Dmel_CG13097 | CG13097 gene product from transcript CG13097-RA |
Echinococcus granulosus | EgrG_000914700 | U3 small nucleolar ribonucleoprotein |
Entamoeba histolytica | EHI_142200 | U3 small nucleolar ribonucleoprotein subunit, putative |
Entamoeba histolytica | EHI_048860 | U3 small nucleolar ribonucleo protein MPP10, putative |
Echinococcus multilocularis | EmuJ_000914700 | U3 small nucleolar ribonucleoprotein |
Giardia lamblia | GL50803_9274 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Homo sapiens | ENSG00000124383 | M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) |
Leishmania braziliensis | LbrM.29.0770 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Leishmania donovani | LdBPK_290780.1 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Leishmania infantum | LinJ.29.0780 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Leishmania major | LmjF.29.0750 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Leishmania mexicana | LmxM.08_29.0750 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Loa Loa (eye worm) | LOAG_08098 | Mpp10 protein |
Mus musculus | ENSMUSG00000030521 | M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) |
Neospora caninum | NCLIV_055310 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Oryza sativa | 4351433 | Os12g0133900 |
Oryza sativa | 4349717 | Os11g0137100 |
Onchocerca volvulus | OVOC9642 | U3 small nucleolar ribonucleoprotein protein MPP10 homolog |
Plasmodium berghei | PBANKA_0511200 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Plasmodium falciparum | PF3D7_1027100 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Plasmodium knowlesi | PKNH_0611500 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Plasmodium vivax | PVX_111365 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Plasmodium yoelii | PY06994 | Arabidopsis thaliana At5g66540/K1F13_21 |
Saccharomyces cerevisiae | YJR002W | Mpp10p |
Schistosoma japonicum | Sjp_0045690 | IPR007151,Mpp10 protein,domain-containing |
Schistosoma mansoni | Smp_023660 | U3 small nucleolar ribonucleoprotein protein MPP10 |
Trypanosoma brucei gambiense | Tbg972.3.3860 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Trypanosoma brucei | Tb927.3.3590 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Trypanosoma congolense | TcIL3000_3_2280 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Trypanosoma cruzi | TcCLB.503811.20 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Trypanosoma cruzi | TcCLB.506989.180 | U3 small nucleolar ribonucleoprotein protein MPP10, putative |
Toxoplasma gondii | TGME49_311410 | M phase phosphoprotein MPP10, putative |
Theileria parva | TP01_0160 | hypothetical protein |
Trichomonas vaginalis | TVAG_166990 | U3 small nucleolar ribonucleoprotein mpp10, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.3590 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.3590 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.3590 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.3590 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y75B8A.7 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y75B8A.7 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_Y75B8A.7 | Caenorhabditis elegans | slow growth | wormbase |
CELE_Y75B8A.7 | Caenorhabditis elegans | sterile | wormbase |
YJR002W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0511200 | Plasmodium berghei | Essential | plasmo |
TGME49_311410 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.